Tacrolimus-induced neurotoxicity in kidney transplant recipients

By Veroux P.   Veroux M.   Puliatti C.   Morale W.   Cappello D.   Valvo M.   Macarone M.  

Transplantation Proceedings, Vol. 34, Iss. 8, 2002-12 ,pp. : 3188-3190

Elsevier

Access to resources Recommend Favorite

Interaction Between Tacrolimus and Itraconazole in a Heart-Lung Transplant Recipient

By Furlan V.   Parquin F.   Penaud J.F.   Cerrina J.   Ladurie F.L.R.   Dartevelle P.   Taburet A.M.  

Transplantation Proceedings, Vol. 30, Iss. 1, 1998-02 ,pp. : 187-188

Elsevier

Access to resources Recommend Favorite

Cyclosporin conversion to CellCept in a cadaveric renal allograft recipient with hemolytic uremic syndrome

By Said T.   Al-Mousawi M.   Samhan M.   Lao M.  

Transplantation Proceedings, Vol. 31, Iss. 8, 1999-12 ,pp. : 3295-3297

Elsevier

Access to resources Recommend Favorite

De novo Hemolytic-Uremic Syndrome/Thrombotic microangiopathy in renal transplant patients receiving calcineurin inhibitors: role of sirolimus

By Franco A.   Hernandez D.   Capdevilla L.   Errasti P.   Gonzalez M.   Ruiz J.C.   Sanchez J.   HUS-Sirolimus Spanish Study Group  

Transplantation Proceedings, Vol. 35, Iss. 5, 2003-08 ,pp. : 1764-1766

Elsevier

Access to resources Recommend Favorite

Reversibility of tacrolimus-induced posttransplant diabetes: an illustrative case and review of the literature

By Shapiro R.   Scantlebury V.P.   Jordan M.L.   Vivas C.   Gritsch H.A.   McCauley J.   Fung J.J.   Hakala T.R.   Simmons R.L.   Starzl T.E.  

Transplantation Proceedings, Vol. 29, Iss. 6, 1997-09 ,pp. : 2737-2738

Elsevier

Access to resources Recommend Favorite